These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7884959)

  • 41. Short-acting beta2-agonists.
    Lee T; Dennis S
    Lancet; 2000 Sep; 356(9233):940-1. PubMed ID: 11036917
    [No Abstract]   [Full Text] [Related]  

  • 42. Salmeterol, a long acting bronchodilator, in the treatment of asthma.
    Morice A
    Ir Med J; 1992 Sep; 85(3):82-3. PubMed ID: 1399485
    [No Abstract]   [Full Text] [Related]  

  • 43. Doping taboos.
    Wolstenholme RJ
    Br J Sports Med; 1995 Dec; 29(4):279. PubMed ID: 8808548
    [No Abstract]   [Full Text] [Related]  

  • 44. Salmeterol-induced vertigo.
    López-Guillen A; Marquès L; López-Llorente MT; Pastor E; Figueras A
    Eur Respir J; 1994 Nov; 7(11):2089-90. PubMed ID: 7875287
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.
    Cheung D; Timmers MC; Zwinderman AH; Bel EH; Dijkman JH; Sterk PJ
    N Engl J Med; 1992 Oct; 327(17):1198-203. PubMed ID: 1357550
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SMART therapy.
    Bell A; McIvor RA
    CMAJ; 2006 Aug; 175(3):276-7. PubMed ID: 16880449
    [No Abstract]   [Full Text] [Related]  

  • 47. Salmeterol: a long acting bronchodilator.
    Bhadoria DP; Bhadoria P
    J Postgrad Med; 1995; 41(1):24-6. PubMed ID: 10740700
    [No Abstract]   [Full Text] [Related]  

  • 48. Salmeterol versus theophylline in the treatment of asthma.
    Pollard SJ; Spector SL; Yancey SW; Cox FM; Emmett A
    Ann Allergy Asthma Immunol; 1997 May; 78(5):457-64. PubMed ID: 9164358
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Salmeterol xinafoate in asthmatic patients under consideration for maintenance oral corticosteroid therapy. UK Study Group.
    Boyd G
    Eur Respir J; 1995 Sep; 8(9):1494-8. PubMed ID: 8575574
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of salmeterol xinafoate powder in children with chronic persistent asthma.
    Weinstein SF; Pearlman DS; Bronsky EA; Byrne A; Arledge T; Liddle R; Stahl E
    Ann Allergy Asthma Immunol; 1998 Jul; 81(1):51-8. PubMed ID: 9690573
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group.
    Simons FE
    N Engl J Med; 1997 Dec; 337(23):1659-65. PubMed ID: 9385125
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Efficacy of and tolerance to salmeterol compared to salbutamol in patients with bronchial asthma].
    De Oliveira MA; Jardim JR; Faresin SM; Lucas SR; Nery LE
    Rev Assoc Med Bras (1992); 1998; 44(3):169-75. PubMed ID: 9755543
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fluticasone/salmeterol: labeling change.
    Prescrire Int; 2008 Dec; 17(98):229. PubMed ID: 19418648
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Long-acting bronchodilators (formoterol and salmeterol) for treatment of asthma].
    Pneumologie; 2009 Apr; 63(4):195-6. PubMed ID: 19343613
    [No Abstract]   [Full Text] [Related]  

  • 55. [Long-acting bronchodilators (formoterol and salmeterol) for treatment of asthma].
    Kardos P
    Pneumologie; 2009 Jan; 63(1):5. PubMed ID: 19153937
    [No Abstract]   [Full Text] [Related]  

  • 56. [Use of glucocorticosteroids in asthmatic conditions (review)].
    Rebrov AP; Karoli NA
    Ter Arkh; 2001; 73(3):63-7. PubMed ID: 11417187
    [No Abstract]   [Full Text] [Related]  

  • 57. Long-acting beta 2-agonist salmeterol compared with albuterol in maintenance asthma therapy.
    Pearlman DS
    Ann Allergy Asthma Immunol; 1995 Aug; 75(2):180-4. PubMed ID: 7648385
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ipratropium for acute asthma in adults.
    Holten KB
    Can Fam Physician; 2000 Dec; 46():2406-7. PubMed ID: 11153407
    [No Abstract]   [Full Text] [Related]  

  • 59. Safety and effectiveness of continuous aerosolized albuterol in the non-intensive care setting.
    Kenyon CC; Fieldston ES; Luan X; Keren R; Zorc JJ
    Pediatrics; 2014 Oct; 134(4):e976-82. PubMed ID: 25266428
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Description of a delivery method for continuously aerosolized albuterol in status asthmaticus.
    Voss KR; Willsie-Ediger SK; Pyszczynski DR; Nelson KA
    J Asthma; 1990; 27(1):37-9. PubMed ID: 2307646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.